Elos Medtech, a prominent player in the medical technology industry, is headquartered in Sweden (SE) and operates extensively across Europe and North America. Founded in 1997, the company has established itself as a leader in the development and manufacturing of advanced medical devices, particularly in orthopaedics and dental applications.
Elos Medtech is renowned for its innovative solutions, including precision-engineered implants and instruments that cater to the specific needs of healthcare professionals. The company’s commitment to quality and sustainability sets it apart in a competitive market, ensuring that its products meet the highest standards of safety and efficacy.
With a strong market position and a reputation for excellence, Elos Medtech continues to achieve significant milestones, contributing to advancements in patient care and enhancing the overall healthcare landscape.
-12 vs industry average
Elos Medtech’s score of 15 is lower than 34% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Elos Medtech?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Medical Device Manufacturing has typical carbon intensity
Industry performance
The Medical Device Manufacturing industry has reduced its overall emissions by 18% since 2019
Emissions trajectory 2020 – 2024
Reported emissions
Scope 3 accounts for ••• of total emissions.
Elos Medtech's reported carbon emissions
In 2024, Elos Medtech reported total carbon emissions of approximately 13,185,000 kg CO2e. This figure represents a significant increase from 2023, when emissions were about 8,639,000 kg CO2e, and from 2022, which saw emissions of approximately 6,795,000 kg CO2e. The company has not disclosed specific data for Scope 1, Scope 2, or Scope 3 emissions, indicating a lack of detailed reporting in these areas. Elos Medtech has not set any formal reduction targets or commitments, as evidenced by the absence of documented reduction initiatives or SBTi targets. The company does not appear to inherit emissions data from a parent organization, as it operates independently without cascading data from a corporate family. Overall, while Elos Medtech's emissions have increased in recent years, the lack of specific reduction commitments or detailed scope reporting highlights an area for potential improvement in their climate strategy.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Elos Medtech’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Elos Medtech yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Elos Medtech
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project